Submit your Center of Excellence Application today!

Read More


Feb 5, 2019

New Retinal Scanner Helps Diagnose Diabetic Retinopathy

New Retinal Scanner Helps Diagnose Diabetic Retinopathy

ELKINS, W.Va. – A new technology at Davis Medical Center (DMC) is designed to help those with diabetes detect diabetic retinopathy in its early stages and avoid possible complications, including blindness. Tiffany Auvil, Nurse Manager of the DMC Population Health Department said the Intelligent Retinal Imaging Systems (IRIS) retinal scanner will be used for diabetic patients who are at least 18 years old and do not have a regular eye doctor.

“Patients who already have an eye doctor and see them yearly should continue to do so,” Auvil said. “The IRIS retinal scanner is for patients who don’t have or don’t regularly see an eye specialist.”

According to the American Optometric Association (AOA), diabetic retinopathy is a condition that occurs in people who have diabetes and causes progressive damage to the retina, the light-sensitive lining at the back of the eye. Diabetic retinopathy is a serious sight-threatening complication of diabetes.

The AOA said in its early stages, diabetic retinopathy has no visual symptoms. Early detection and treatment can limit the potential for significant vision loss from diabetic retinopathy.

“The IRIS technology allows us to keep an eye on our patient’s eyes,” Auvil said. “The longer someone has diabetes, the more likely they will develop diabetic retinopathy and if left untreated, it can cause blindness.”

Dilation of the eye is not necessary to perform the IRIS scan, and the test can often be combined with a patient’s regular visit to their primary care physician which could eliminate the cost of a trip to an eye specialist for similar testing.  Once the diabetic patient’s scan is complete, IRIS ophthalmologists read and interpret the results of the images. The results are sent back to the patient’s doctor at DMC within 24 to 48 hours…..

Read more:

Source: Parsons Advocate

Leave a Reply

Your email address will not be published. Required fields are marked *

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.